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LONG-TERM RESIDENCE OF A GRAFT IS AN
INSUFFICIENT STIMULUS FOR THE
INDUCTION OF TOLERANCE
Investigating the Role of Cyclosporine in Class I-disparate
Heart Grafts in the Rat .
BY SUSAN M. L. LIM AND DAVID J . G. WHITE
From the Department of Surgery, Addenbrookes Hospital, Cambridge CB2 2QQ, United Kingdom
We (1-4) and others (5-7) have previouslydemonstrated the ability ofa short period
of Cyclosporine A (CyA) treatment to produce prolonged, stable, donor-specific al-
lograft tolerance in rats. An understanding of the mechanism of induction of this
tolerance is clearly a prerequisite for its application to man. It is known that con-
tinued antigen presence (8, 9) is essential for the maintenance of this state. The re-
cent availability of congenic rat strains (10, 11) has enabled us to address the issue
of the role of the MHC antigens versus the role of the CyA treatment in the induc-
tion of tolerance. By using congenic, class 1-incompatible rat strains, we have been
able to analyze the influence of the long-term residence of heart grafts on the im-
munological status of the recipients, with and without CyA treatment .
Materials and Methods
Rat Strains.
￿
Four levels of mismatch at the MHC (full, major, class II, and class I) were
studied. This was achieved using DA (RT1.AaBa) rats and the following PVG congenics: PVG
(RT1.AcBc), PVG-RTla (RT1 .AaBa), and PVG-RTlrl(RT1 .AaBc), in the combinations as
detailed in Table I. WAGS(RT1.AuBu) were used as third-party donors. All were males; donors
weighed 100-150 g; recipients 200-250 g. All rats were obtained from Olac Ltd., Bicester,
Oxon, England .
Heart Grafts.
￿
Accessory cervical heart transplantation was performed by the technique
described by Heron (12). The aorta and pulmonary artery ofthe donorheart were anastomosed
to the common carotid artery and external jugular vein of the recipient, respectively, using
an external cuff technique. The transplanted hearts were checked by daily inspection and
palpation. Rejection was diagnosed by the cessation of heartbeat and confirmed in all cases
by histological examination.
Skin Grafts.
￿
Full-thickness skins were grafted onto recipients bearing functioning heart
grafts for >100 d. Skins were raised from the ventral abdominal wall of donors, trimmed of
fat, sutured onto recipient flank beds prepared with meticulous hemostasis using continuous
6/0 silk, and bandaged with elastoplast. Dressings were removed on day 5 . No further treat-
ment was given. Rejection was said to have occurred when >50% of the graft surface had
become raised, necrotic, or scabby.
Immunosuppression.
￿
CyA (gift from Sandoz Ltd., Basel, Switzerland) was administered in-
tramuscularly in olive oil at a dose of 15 mg/kg/d for 17 d according to the intermittent treat-
ment schedule (3) (treatment days 0-6, 21-27, 42-44). This schedule was previously shown
to be effective in maintaing CyA blood levels >300 ng/mL for 60 d, and in so doing, toler-
ance to heart grafts could be achieved in a very high percentage of cases.
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Experimental Design.
￿
20 hearts were grafted across each of the levels of mismatch studied
(full, major, class II, class I). These were subdivided at each level into untreated controls
(n = 10), and CyA-treated animals (n = 10). As a test for tolerance, long-term survivors
with functioning heart grafts >100 d, were grafted with donor-specific, as well as third-party
(WAG) skins.
Results and Discussion
The role of MHC antigens in the induction of tolerance to heart grafts was inves-
tigated. The data from Table I, groups la, 2a, and 3a, demonstrate that a class II
incompatibility whether alone (median survival time [MST] 13.9 d) or in combina-
tion with a class I (MST, 6.3 d), or class I and minor incompatibility (MST, 7.4
d), causes the heart graft to be rejected. With CyA treatment however, tolerance was
successfully induced in these groups. This was confirmed by the ability to accept
donor-specific skin grafts for at least the length of the observation period of 50 d,
whereas third-party skin (WAG) was rejected in near normal time (MST, 9.7 d).
The critical observation, however, is in group 4 of Table I where hearts are grafted
across a class I barrier only. Under these circumstances, even without CyA, all the
heart grafts survive indefinitely. However, subsequent donor-specific skin grafts are
rejected (MST, 20.6 d) demonstrating that despite the long-term residence of the
heart graft, systemic tolerance fails to develop. Is the failure to develop tolerance
in this group due to a lack of appropriate antigenic stimulation or a lack of CyA?
Group4b demonstrates that when theseclassI-incompatible heart grafts are treated
with CyA, despite this being unnecessary to retain the graft, such treatment now
induces allograft tolerance, as demonstrated by donor skin acceptance. Since the
only difference between these two groups is the CyA treatment, it is concluded that
CyA plays an active part in the induction of allograft tolerance where the prolonged
presence of a heart graft alone failed to do so.
TABLE I
The Induction of Tolerance by CyA Across Various Levels ofMHC Mismatch in the Rat
Heterotopic heart grafts (HG) were performed across four levels of MHC mismatch in the rat; full (major
and minor), major (classes I and II), class II, and class I. Each group was subdivided into a no treatment
and CyA treatment (CyA Rx) subgroup of 10 animals each. Long-term survivors (LTS) with functioning
heart grafts >100 d were tested for systemic tolerance by grafting with donor-specific (DS) and third-party
(TP) skins. Tolerance was confirmed by donor-specific skin graft (SG) survival >50 d.
Group Donor Recipient Mismatch
Cy
Rx
HG median
survival
(n = 10)
SG median
survival
on LTS (n =
DS TP
d d
la DA PVG Major and - 7 - -
minor
lb DA PVG Major and Yes 100 50 10
minor
2a PGV-RTla PVG Major - 6 - -
2b PGV-RTla PVG Major Yes 100 50 9
3a PVG-RTlrl PVG-RTla Class II - 12 - -
3b PVG-RTlrl PVG-RTla Class II Yes 100 50 10
4a PVG-RTlrl PVG Class I - 100 20 10
46 PVG-RTlrl PVG Class I Yes 100 50 10The term "tolerance" has been used to describe a variety of unresponsive states.
The criteria used here for the definition oftolerance is specific, systemic, nonrespon-
siveness to donor strain antigens as demonstrated by the failure of the animal to
reject a skin graft of donor origin. In this study, we were able to generate long term
survivors (LTS; defined as recipients with functioning heart grafts >100 d) in five
groups, of which four received CyA treatment (groups lb, 2b, 3b, 4b), and one did
not (group 4a). We demonstrate, however, that only those groups treated with CyA
developed specific, systemic tolerance (Table I, groups 1b, 2b, 3b, 4b). These results
appear to differ from the studies of Pescovitz et al. (13), who looked at the effect
of class II antigen matching on renal allograft survival in miniature swine. However,
it is appreciated that both the organ graft studied, and the experimental modelused,
were different.
Summary
This study demonstrates that the induction of tolerance is possible across a class
I only antigenic barrier that fails to produce heart graft rejection. However, the long-
term residence alone of such a graft per se, does not necessarily lead to the establish-
ment of systemic tolerance in the recipient. The important finding in this study with
regard to the biology of allognaft tolerance, is that while the class I antigen provides
the stimulus, its presence alone is not sufficient for the induction of tolerance; in-
deed, the action of the Cyclosporine A (CyA) is a necessary adjunct to its induction.
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